ACADIA Pharmaceuticals Inc(ACAD)
15.45
Change: -0.56 (▼ -3.65%)
As of Wed 12/21/2022 12:40 AM% Of Value
Growth
Value Per Share
:
:
:
-245.93
9.60
-4.3400 (as of 20/12/2022)
Fundamentals Data
| Open | 15.00 | Dividend | 116 |
| Close Price | 15.45 | DivYield | 0 % |
| High | 15.545 | Growth | 42.3 M |
| Low | 14.8 | Growth% | 9.60 |
| P/e | -14.981 | Volume | 932,872.0 |
| P/b | -1.93 | Market Capital | 2.4 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 15.44 (as of 20/12/2022) | 50 Days Moving Average Percentage | -2.276821192053 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 124.9 M | 223.8 M | 339.0 M | 441.7 M | 484.1 M |
| Cap Spending | -812,000.0 | -2.1 M | -1.1 M | -7.5 M | -1.1 M |
| Operating Expenses | 408.2 M | 460.7 M | 574.2 M | 718.1 M | 643.7 M |
| Operating Cash Flow | -292.4 M | -249.2 M | -246.5 M | -286.5 M | -170.4 M |
| Free Cash Flow | -218.6 M | -169.5 M | -152.2 M | -143.7 M | -126.7 M |
| Free Cash Flow Per Share | -1.784 | -1.34 | -1.034 | -0.914 | -0.79 |
| Total liabilities | 0.0 | 0.0 | 6.3 M | 44.4 M | 56.1 M |
| Total cash | 71.8 M | 139.5 M | 194.4 M | 331.7 M | 153.2 M |
| ROE% | -0.73 | -0.771 | -0.429 | -0.436 | -0.298 |
| Outstanding Shares | 124.7 M | 143.8 M | 155.3 M | 160.0 M | 161.2 M |
| P/E | -13.427 | -14.981 | -25.817 | -26.89 | -24.074 |
| P/S | 31.11 | 16.413 | 17.913 | 17.14 | 8.347 |
| Revenue USD | 124.9 M | 223.8 M | 339.0 M | 441.7 M | 484.1 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|